These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2866766)

  • 1. Octapeptide analogs of somatostatin exhibiting greatly enhanced in vivo and in vitro inhibition of growth hormone secretion in the rat.
    Murphy WA; Heiman ML; Lance VA; Mezo I; Coy DH
    Biochem Biophys Res Commun; 1985 Nov; 132(3):922-8. PubMed ID: 2866766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel heptapeptide somatostatin analog displays anti-tumor activity independent of effects on growth hormone secretion.
    Murphy WA; Taylor JE; Moreau JP; Coy DH
    Pept Res; 1989; 2(1):128-32. PubMed ID: 2577697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative potencies of the somatostatin analogs octreotide, BIM-23014, and RC-160 on the inhibition of hormone release by cultured human endocrine tumor cells and normal rat anterior pituitary cells.
    Hofland LJ; van Koetsveld PM; Waaijers M; Zuyderwijk J; Lamberts SW
    Endocrinology; 1994 Jan; 134(1):301-6. PubMed ID: 7903931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superactive octapeptide somatostatin analogs containing tryptophan at position 1.
    Cai RZ; Karashima T; Guoth J; Szoke B; Olsen D; Schally AV
    Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2502-6. PubMed ID: 2882520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of highly potent octapeptide analogs of somatostatin on growth hormone, insulin and glucagon release.
    Karashima T; Cai RZ; Schally AV
    Life Sci; 1987 Aug; 41(8):1011-9. PubMed ID: 2886886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid-phase synthesis and biological properties of psi [CH2NH] pseudopeptide analogues of a highly potent somatostatin octapeptide.
    Sasaki Y; Murphy WA; Heiman ML; Lance VA; Coy DH
    J Med Chem; 1987 Jul; 30(7):1162-6. PubMed ID: 2885417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin analogs: correlation between receptor binding affinity and biological potency in GH pituitary cells.
    Schonbrunn A; Rorstad OP; Westendorf JM; Martin JB
    Endocrinology; 1983 Nov; 113(5):1559-67. PubMed ID: 6138246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemistry and pharmacology of SMS 201-995, a long-acting octapeptide analogue of somatostatin.
    Pless J; Bauer W; Briner U; Doepfner W; Marbach P; Maurer R; Petcher TJ; Reubi JC; Vonderscher J
    Scand J Gastroenterol Suppl; 1986; 119():54-64. PubMed ID: 2876507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissociation between the effects of somatostatin (SS) and octapeptide SS-analogs on hormone release in a small subgroup of pituitary- and islet cell tumors.
    Hofland LJ; De Herder WW; Visser-Wisselaar HA; Van Uffelen C; Waaijers M; Zuyderwijk J; Uitterlinden P; Kros MJ; Van Koetsveld PM; Lamberts SW
    J Clin Endocrinol Metab; 1997 Sep; 82(9):3011-8. PubMed ID: 9284735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lanthionine-somatostatin analogs: synthesis, characterization, biological activity, and enzymatic stability studies.
    Osapay G; Prokai L; Kim HS; Medzihradszky KF; Coy DH; Liapakis G; Reisine T; Melacini G; Zhu Q; Wang SH; Mattern RH; Goodman M
    J Med Chem; 1997 Jul; 40(14):2241-51. PubMed ID: 9216843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of rat prostate tumor growth by an octapeptide analog of somatostatin.
    Murphy WA; Lance VA; Moreau S; Moreau JP; Coy DH
    Life Sci; 1987 Jun; 40(26):2515-22. PubMed ID: 2885701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides.
    Raynor K; Murphy WA; Coy DH; Taylor JE; Moreau JP; Yasuda K; Bell GI; Reisine T
    Mol Pharmacol; 1993 Jun; 43(6):838-44. PubMed ID: 8100350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin octapeptides (lanreotide, octreotide, vapreotide, and their analogs) share the growth hormone-releasing peptide receptor in the human pituitary gland.
    Deghenghi R; Papotti M; Ghigo E; Muccioli G; Locatelli V
    Endocrine; 2001 Feb; 14(1):29-33. PubMed ID: 11322499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel long-acting somatostatin analog with endocrine selectivity: potent suppression of growth hormone but not of insulin.
    Afargan M; Janson ET; Gelerman G; Rosenfeld R; Ziv O; Karpov O; Wolf A; Bracha M; Shohat D; Liapakis G; Gilon C; Hoffman A; Stephensky D; Oberg K
    Endocrinology; 2001 Jan; 142(1):477-86. PubMed ID: 11145612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action.
    Bauer W; Briner U; Doepfner W; Haller R; Huguenin R; Marbach P; Petcher TJ; Pless
    Life Sci; 1982 Sep; 31(11):1133-40. PubMed ID: 6128648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central and peripheral actions of somatostatin on the growth hormone-IGF-I axis.
    Murray RD; Kim K; Ren SG; Chelly M; Umehara Y; Melmed S
    J Clin Invest; 2004 Aug; 114(3):349-56. PubMed ID: 15286801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent, highly selective inhibition of growth hormone secretion by position 4 somatostatin analogs.
    Murphy WA; Meyers CA; Coy DH
    Endocrinology; 1981 Aug; 109(2):491-5. PubMed ID: 6113951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin: analogs with selected biological activities.
    Brown M; Rivier J; Vale W
    Science; 1977 Jun; 196(4297):1467-9. PubMed ID: 867045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological activities of tyrosine-containing somatostatin analogs on inhibition of secretion of thyrotropin and growth hormone.
    Ohashi S; Sawano S; Kokubu T; Gondo M; Sakakibara K
    Endocrinol Jpn; 1976 Oct; 23(5):435-8. PubMed ID: 1009896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro.
    Hofland LJ; van der Hoek J; van Koetsveld PM; de Herder WW; Waaijers M; Sprij-Mooij D; Bruns C; Weckbecker G; Feelders R; van der Lely AJ; Beckers A; Lamberts SW
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1577-85. PubMed ID: 15070915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.